The Immune System – Products

The mechanism targets both integrated virus and cccDNA; expected to begin clinical testing by end of 2024. Preclinical program data to be presented at the 2023 Hep DART Conference .

A multitude of resistance genes in crop genomes could be brought back to life.

Xsphera Biosciences, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I, a Seoul-based pioneer in immune-oncology therapeutics.

Proteintech Genomics, a subsidiary of Proteintech Group, inc., and a provider of multiomic solutions for single-cell and spatial analysis, announced the launch of the MultiPro™ Human Fixed Cell Immune Profiling Antibody Cocktail.

Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.

Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.

At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.

Sartorius, has released its first Advanced Flow Cytometry Handbook as a comprehensive digital guide to assays and workflows on the iQue® Advanced High Throughput Flow Cytometry Platform.

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.

Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®.